Defunct Company
Total Trials
7
As Lead Sponsor
As Collaborator
0
Total Enrollment
1,238
NCT00404612
A Study of LX211 in Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-Uveitis
Phase: Phase 3
Role: Lead Sponsor
Start: Jan 31, 2007
Completion: May 31, 2009
NCT00404742
A Study of LX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-Uveitis
NCT00404885
A Multi-center Study to Assess the Efficacy and Safety of LX211 in Active Non-infectious Anterior Uveitis
NCT00447187
Study to Assess the Efficacy and Safety of LX201 for Prevention of Corneal Allograft Rejection Episodes and Graft Failure in Subjects at Increased Immunological Risk
Start: Apr 30, 2007
Completion: Nov 30, 2010
NCT00447642
Study to Assess LX201 for Prevention of Corneal Allograft Rejection or Graft Failure in Subjects Who Have Experienced One or More Rejection Episodes Following Penetrating Keratoplasty
Completion: Jan 31, 2010
NCT00851734
A Dose-Escalation Study to Assess the Safety and Tolerability of LX214 Ophthalmic Solution in Healthy Volunteers, Followed by an Open-Label Evaluation of LX214 in Patients With Keratoconjunctivitis Sicca (KCS)
Phase: Phase 1
Start: Feb 28, 2009
Completion: Apr 30, 2009
NCT01243983
Efficacy and Safety of Voclosporin to Treat Active Noninfectious Uveitis
Start: Feb 28, 2011
Completion: Dec 31, 2012